Literature DB >> 9989419

Preoperative angiography and embolization of large pelvic tumors.

M Salai1, A Garniek, Z Rubinstein, A Segal, B Morag.   

Abstract

BACKGROUND AND OBJECTIVES: Pelvic tumors are often large and difficult to excise with appropriate surgical margins due to their size, proximity to neurovascular structures, and major intraoperative bleeding. The purpose of this study is to evaluate the yield of preoperative angiography and embolization so as to facilitate achievement of good surgical results.
METHODS: Eighteen patients who suffered from large pelvic tumors (average size, 10.7 cm x 8.3 cm x 3.7 cm), 15 primary and 3 metastatic, underwent surgery at our institution between 1990 and 1995, after preoperative angiography and embolization of the tumors.
RESULTS: The efficacy of the procedure was high. In all but one patient, the grade of vascularity of the tumor was reduced by at least two levels (based on our new tumor vascularity scale. In most patients, appropriate surgical margins were achieved. The average perioperative blood loss was only 750 cc. Procedure-associated complications were negligible.
CONCLUSIONS: The results of this study call for the use of angiography and embolization in the management of patients with large pelvic tumors.

Entities:  

Mesh:

Year:  1999        PMID: 9989419     DOI: 10.1002/(sici)1096-9098(199901)70:1<41::aid-jso7>3.0.co;2-q

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Arterial embolization to preoperatively manage pulmonary disease associated with inflammation.

Authors:  Tohru Sakuragi; Yukinori Sakao; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

2.  Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study.

Authors:  Nawfal Al-Hadithy; Panagiotis Gikas; Jonathan Perera; Will Aston; Rob Pollock; John Skinner; Kevin Lotzof; Steve Cannon; Tim W Briggs
Journal:  World J Oncol       Date:  2011-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.